Celldex Therapeutics reported that its medicine for a condition that causes chronic hives reduced hive activity and, notably, ...

A little over a year ago, I woke up in the middle of the night with an itchy scalp. I didn’t give it much thought, assuming ...

Urticaria may be acute or chronic. As opposed to acute urticaria, chronic urticaria is defined by recurrent episodes occurring at least twice a week for 6 weeks (Grattan, Sabroe, & Greaves ...

Sanofi and Regeneron’s blockbuster drug Dupixent successfully treated patients with chronic spontaneous urticaria, an inflammatory skin disease, in a late-stage trial, the companies announced on ...

Celldex Therapeutics has unveiled 52-week results from a mid-stage study of its anti-KIT drug in chronic hives, raising ...

Every year, on October 1st, is World Urticaria Day, a day dedicated to raising awareness about urticaria, commonly known as ...

Patients with chronic spontaneous urticaria improved early, with benefits lasting through the 52-week follow-up for those who ...

The incidence of mental disorders such as anxiety, depression, and sleep disturbance was higher among patients with chronic urticaria (CU) than in patients with acute urticaria (AU). Medication ...

The Food and Drug Administration rejected the companies’ initial application in chronic spontaneous urticaria, or CSU, last year, requesting additional efficacy data to support the new use.

(150 mg Q4W) achieved complete response at Week 52 -- Rapid, profound and durable improvement in UAS7 as early as Week 1 with a ...

(RTTNews) - Celldex Therapeutics, Inc. (CLDX), Wednesday announced results from phase 2 study of barzolvolimab for treatment of chronic spontaneous urticaria, an immune-related condition. At the end ...